《Journal Of Oncology》重点专注发布Medicine-Oncology领域的新研究，旨在促进和传播该领域相关的新技术和新知识。鼓励该领域研究者详细地发表他们的高质量实验研究和理论结果。该杂志创刊至今，在Medicine-Oncology领域，有较高影响力，对来稿文章质量要求较高，稿件投稿过审难度较大。欢迎广大同领域研究者投稿该杂志。
| CiteScore | SJR | SNIP | CiteScore排名 | |||
|---|---|---|---|---|---|---|
| 3.9 | 0.805 | 0.806 | 学科类别 | 分区 | 排名 | 百分位 |
|
大类：大类：Medicine
小类：小类：Oncology
|
Q3 | 204/366 | 44% | |||
| 按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|
文章名称
引用次数
Current Challenges in Cancer Immunotherapy: Multimodal Approaches to Improve Efficacy and Patient Response Rates
40
Combinatorial Approach to Improve Cancer Immunotherapy: Rational Drug Design Strategy to Simultaneously Hit Multiple Targets to Kill Tumor Cells and to Activate the Immune System
31
Human Papillomavirus Infection and Cervical Cancer: Epidemiology, Screening, and Vaccination-Review of Current Perspectives
24
Notch Signaling Activation as a Hallmark for Triple-Negative Breast Cancer Subtype
21
Extracellular Vesicles and Their Potential Use in Monitoring Cancer Progression and Therapy: The Contribution of Proteomics
20
LncRNA PVT1 Mediates Antiapoptosis and 5-Fluorouracil Resistance via Increasing Bcl2 Expression in Gastric Cancer
20
Current and Emerging Targets in Immunotherapy for Osteosarcoma
19
Circular RNA hsa_circ_0007142 Is Upregulated and Targets miR-103a-2-5p in Colorectal Cancer
19
Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience
17
Long-Term Survival, Quality of Life, and Psychosocial Outcomes in Advanced Melanoma Patients Treated with Immune Checkpoint Inhibitors
17
国家/地区
发文量
TCHINA MAINLAND
183
TUSA
91
TItaly
61
TGERMANY (FED REP GER)
24
TTurkey
21
TEngland
18
TJapan
16
TSouth Korea
16
TBrazil
14
TAustralia
13
